Emerging Diseases News

SEATTLE — An intervention called LinkUP improved rates of COVID-19 testing and vaccination referral acceptance among people who inject drugs, with increased impact among those experiencing homeless, researchers found.

Glucocorticoids alone demonstrate similar recovery rates as intravenous immunoglobin, or combination therapy with both, in patients with multisystem inflammatory syndrome in children, according to data published in The Lancet Rheumatology.

The FDA approved rezafungin for injection to treat candidemia and invasive candidiasis in adults, offering a new treatment for people with limited or no other options.

Candida auris cases and transmission have dramatically increased in recent years, with 17 states identifying their first case from 2019 to 2021, according to a study published in Annals of Internal Medicine.

The public health and national emergencies related to the COVID-19 pandemic are set to end on May 11.

The public health and national emergencies related to the COVID-19 pandemic are set to end on May 11.

My journey in infectious diseases started out with an intense hatred and utter confusion.

Researchers estimated that more than half of children aged 9 to 13 in the U.S. Virgin Islands have been previously infected with dengue virus, making them eligible for vaccination, according to findings published in MMWR.

The FDA’s Antimicrobial Drugs Advisory Committee voted Thursday to support the approval of Paxlovid for the treatment of mild-to-moderate COVID-19 in adults at high risk for severe disease, hospitalization or death.

The FDA said children aged 6 months to 4 years who completed a three-dose series of Pfizer-BioNTech’s monovalent COVID-19 vaccine can now receive the company’s bivalent booster under an expanded emergency use authorization.